Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent

Propranolol (PRO) is a well-known and widely used non-selective beta-adrenergic receptor antagonist (beta-blocker), with a range of actions which are of interest in an oncological context. PRO displays effects on cellular proliferation and invasion, on the immune system, on the angiogenic cascade, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantziarka, Pan, Bouche, Gauthier, Sukhatme, Vidula, Meheus, Lydie, Rooman, Ilse, Sukhatme, Vikas P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102691/
https://www.ncbi.nlm.nih.gov/pubmed/27899953
http://dx.doi.org/10.3332/ecancer.2016.680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102691/
https://www.ncbi.nlm.nih.gov/pubmed/27899953
http://dx.doi.org/10.3332/ecancer.2016.680

Ejemplares similares